Journal Pharmaceutical Science and Application (JPSA)
Vol. 1 No. 1 (2012): Journal Pharmaceutical Science and Application (JPSA)

Antihypertensive Drug Use in Patient With Intracerebral Hemorrhage Stroke

Larasanty, Luh Putu Febryana (Unknown)



Article Info

Publish Date
01 Jun 2012

Abstract

Intracerebral hemorrhage (ICH) stroke is a type of stroke with the highest mortality rate, with only about 38% of patients who survived for the first year after stroke. Antihypertensive treatment one of the main therapy for reduce the mortality rate in ICH. Based on review from research study journals, peer review journals, guidelines or book about use of antihypertensive drugs in ICH stroke patient and/or hypertensive emergency, uses of nicardipine, labetalol, esmolol and enalapril can be as the first-line therapy to manage acute high blood pressure in intracerebral hemorrhage stroke if there is no contraindication or caution is present. Nicardipine, labetalol, esmolol and enalapril is four agent that reduce blood pressure in a titratable fashion and do not lead increases in intracranial pressure. Hydralazine, sodium nitroprusside and nitroglycerine can be used as alternative agent if nicardipine, labetalol, esmolol and enalapril can not be used in ICH stroke patient. Keywords: Stroke, Intracerebral Hemorrhage, Antihypertensive Agent

Copyrights © 2012






Journal Info

Abbrev

jpsa

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Immunology & microbiology Materials Science & Nanotechnology Medicine & Pharmacology Public Health Social Sciences Other

Description

Journal Pharmaceutical Science and Application (JPSA) publishes high-quality original research articles, review articles, and short communications that contribute substantially to the advancement of knowledge in the field of pharmaceutical sciences and their applications. The journal welcomes ...